M&A Deal Summary

Fresenius Medical Care Acquires Hema Metrics

On March 8, 2011, Fresenius Medical Care acquired medical products company Hema Metrics

Acquisition Highlights
  • This is Fresenius Medical Care’s 3rd transaction in the Medical Products sector.
  • This is Fresenius Medical Care’s 5th transaction in the United States.
  • This is Fresenius Medical Care’s 1st transaction in Utah.

M&A Deal Summary

Date 2011-03-08
Target Hema Metrics
Sector Medical Products
Buyer(s) Fresenius Medical Care
Deal Type Add-on Acquisition

Target

Hema Metrics

Kaysville, Utah, United States
Hema Metrics LLC is a medical monitoring devices company manufactures and distributes blood pressure and oxygen therapy equipment.

Search 177,534 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Fresenius Medical Care

Bad Homburg, Germany

website


Category Company
Founded 1996
Sector Healthcare Services
Employees123,538
Revenue 17.9B EUR (2020)
DESCRIPTION

Fresenius Medical Care a kidney dialysis company, provides renal dialysis products and services. Fresenius Medical Care was founded in 1996 and is based in Bad Homburg, Germany.


DEAL STATS #
Overall 6 of 16
Sector (Medical Products) 3 of 6
Type (Add-on Acquisition) 5 of 15
State (Utah) 1 of 1
Country (United States) 5 of 12
Year (2011) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-20 Renal Advantage

Franklin, Tennessee, United States

Renal Advantage Inc., is a national provider of high-quality dialysis services. RAI has more than 150 outpatient dialysis centers across the United States and has quickly become the third largest provider of dialysis and home dialysis services in the country.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-07 American Access Care

Glen Rock, Pennsylvania, United States

American Access Care is a management company operating freestanding outpatient vascular access centers dedicated to patients suffering from end-stage renal disease (ESRD).

Buy -